NCT07136883 - DCB Outcomes After Plain or Scoring Balloon for Vessel Preparation in Patients With Femoropopliteal Arterial Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions

Femoropopliteal DiseaseDrug Coated BalloonCritical Limb Ischemia (CLI)Peripheral Arterial Disease

Interventions

DEVICE

POBA

The intervention consists of preparing the artery with a traditional/regular angioplasty balloon before using the DCB (Luminor™; Manufacturer: iVascular, S.L.U., Barcelona, Spain) as the definitive treatment.

DEVICE

Scoring Balloon

The intervention consists of preparing the artery with a scoring balloon (Angiosculpt™; Manufacturer: Spectranetics Corporation, Fremont, California, USA) before using the DCB (Luminor™; Manufacturer: iVascular, S.L.U., Barcelona, Spain) as the definitive treatment.

Trial Locations (1)

08402

Fundació Privada Hospital Asil de Granollers, Granollers

All Listed Sponsors

lead

Marc Sirvent

OTHER